Kidswell Bio Corporation
4584.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥4,536,302 | ¥5,054,322 | ¥8,103,473 | ¥14,191,595 |
| - Cash | ¥2,995,435 | ¥2,231,411 | ¥1,067,162 | ¥1,160,934 |
| + Debt | ¥1,837,960 | ¥2,575,000 | ¥1,950,000 | ¥700,000 |
| Enterprise Value | ¥3,378,827 | ¥5,397,911 | ¥8,986,311 | ¥13,730,661 |
| Revenue | ¥5,082,053 | ¥2,431,235 | ¥2,776,240 | ¥1,569,231 |
| % Growth | 109% | -12.4% | 76.9% | – |
| Gross Profit | ¥1,639,223 | ¥1,039,383 | ¥1,525,687 | ¥1,018,874 |
| % Margin | 32.3% | 42.8% | 55% | 64.9% |
| EBITDA | ¥116,264 | -¥1,380,821 | -¥620,453 | -¥531,893 |
| % Margin | 2.3% | -56.8% | -22.3% | -33.9% |
| Net Income | -¥21,140 | -¥1,422,078 | -¥657,434 | -¥550,863 |
| % Margin | -0.4% | -58.5% | -23.7% | -35.1% |
| EPS Diluted | -0.52 | -40.23 | -20.77 | -17.86 |
| % Growth | 98.7% | -93.7% | -16.3% | – |
| Operating Cash Flow | ¥936,707 | -¥453,634 | -¥1,421,259 | -¥1,169,561 |
| Capital Expenditures | -¥6,444 | ¥453,634 | ¥1,421,259 | -¥160 |
| Free Cash Flow | ¥930,263 | -¥453,634 | -¥1,421,259 | -¥1,169,721 |